CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based ...

Advancements in Bioprinting and Personalized Patient Care Drive Exponential Growth in the Medical Additive Manufacturing Sector.Austin, United States, April 08, 2026 (GLOBE NEWSWIRE) -- SNS Insider ...

Aspect Biosystems, a biotechnology company pioneering a novel category of regenerative medicine, today announced that it has received a $79 million investment from the Government of Canada.

Chitosan-based hydrogel is capable of responding to chemical signals, providing potential for new material approach for 3D ...

Aspect Biosystems, a biotechnology company pioneering a novel category of regenerative medicine, today announced that it has received a $79 million investment from the Government of Canada.

Strengthening British Columbia's life sciences sector by supporting projects that advance emerging Canadian technologies and enhance the innovation ecosystem VANCOUVER, BC, April 2, 2026 /CNW/ - Today ...

During a visit to Vancouver Wednesday, Industry Minster Mélanie Joly announced two investments in Canada’s life sciences sector, including $79 million for the nation’s first bioprinting facility for ...

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies ...

Building functional human muscle in the laboratory has long been a goal of regenerative medicine, but one stubborn obstacle remains: real muscle is not just a mass of cells. Its strength and function ...

REHOVOT, Israel, Feb. 23, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary ...

PEMBROKE PARK, Fla. — October is Breast Cancer Awareness Month, and this year alone, more than 316,000 women in the U.S. are projected to be diagnosed with an invasive form of the disease, according ...